Bright Uro Adds Two Industry Pioneers to Its Board of Directors
Will Conmed (CNMD) Beat Estimates Again in Its Next Earnings Report?
Conmed Corp (CNMD) Q2 2024 Earnings Call Highlights: Record Sales Amid Supply Chain Challenges
Here's Why You Should Retain CONMED Stock in Your Portfolio
Wells Fargo Remains a Hold on Conmed (CNMD)
Assessing Conmed: Insights From 6 Financial Analysts
Conmed Analyst Ratings
Needham Maintains ConMed(CNMD.US) With Buy Rating, Maintains Target Price $97
Analysts Have Conflicting Sentiments on These Healthcare Companies: Trevi Therapeutics (TRVI), Conmed (CNMD) and Revance Therapeutics (RVNC)
Conmed Reports Preliminary Q3 Revenue $315M-$318M, Consensus $318.73M
CONMED Sees Q3 Revenues A Tad Below Estimates
Express News | Conmed Corp Q3 Shr View $0.99, Rev View $318.7 Mln -- LSEG IBES Data
Express News | Conmed Corp: Q3 Adj EPS Growth in Excess of Previously Provided Guidance of 9% to 11%
Express News | Conmed Corporation Announces Preliminary Third Quarter Financial Information
CONMED Corporation Announces Preliminary Third Quarter Financial Information
Conmed Sees 3Q Rev $315M-$318M >CNMD
Are Investors Undervaluing CONMED Corporation (NYSE:CNMD) By 48%?
Wells Fargo Maintains ConMed(CNMD.US) With Hold Rating
Analysts Have Conflicting Sentiments on These Healthcare Companies: Conmed (CNMD) and Ironwood Pharma (IRWD)
Conmed (CNMD) Gets a Hold From Wells Fargo